"Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod." Neurology - Neuroimmunology Neuroinflammation
9.4
(2022):
e1178.
Web. 30 May. 2023.
Advertisement